Lectures
2020
05.11.2020 Seminar „Modern Analytical Chemistry“ at the Institute of Chemical Technologies and Analytics, invited by Prof. Ruth Birner-Grünberger
Astrid Slany: “High-resolution mass spectrometry-based proteomics applied in cancer research”
17.10.2020 Österreichischer Myelomtag 2020
Astrid Slany: “Die treibenden Kräfte des Myeloms“
10.07.2020 University of Vienna, Department of Analytical Chemistry, Habilitation Colloquium
Samuel M. Meier-Menches: “Mass Spectrometry for Elucidating Activation Mechanisms and Modes of Action of Anticancer Metallodrugs on the Molecular Level”
25.05.2020 University of Vienna, Department of Analytical Chemistry, Habilitation Colloquium
Astrid Slany: “Multi-omics analyses of cancer development and progression under special consideration of the tumor microenvironment”
05.03.2020 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger
Samuel M. Meier-Menches: “Mass Spectrometric Techniques to Study Reactive Metallodrugs on the Molecular Level”
2019
14.11.2019 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger
Astrid Slany: “Analytical tools and strategies to get insights into tumor pathophysiologies”
19.-22.09.2019 EPMA World Congress 2019, Pilsen, Tschechien
Christopher Gerner (plenary lecture): “Multi-omic patterns in body fluids: Technological challenge with a great potential to implement the advanced paradigm of 3P Medicine”
16.07.2019 Biomolecular Imaging Meets Immuno-Oncology Symposium, University of Regensburg, Germany
Astrid Slany: “Multi-omics analysis to reveal immune evasion and metabolic strategies of tumor cells”
24.04.2019 WoChem Symposium 2019, University of Vienna, Faculty of Chemistry
Astrid Slany: “Application of in-depth proteome profiling based on high resolution mass spectrometry to reveal patho-physiological mechanisms”
19.-20.02.2019 30th MassSpec-Forum Vienna 2019, University of Vienna, Faculty of Chemistry
Lukas Janker: “Deoxynivalenol and A431 epidermoid squamous carcinoma cells: proteomic profiling reveals the pathways connecting ribosomal inhibition with a loss of function of the cell membrane”
2018
06.12.2018 Vienna-Tau collaboration on: melanoma brain metastasis, Tel Aviv
Christopher Gerner: "Metabolomics, lipidomics and proteomics unravel the role of neutrophils for ovarian cancer and melanoma metastases"
Benjamin Neuditschko: "Up for a challenge? Proteome profiling of cutaneous melanoma cells and their cerebral metastases suggest individually distinct metastasis mechanisms"
Benjamin Neuditschko: "Examining the challenge! Proteomic evaluation of the Ruthenium drug IT-139 and its potential use for anti-metastatic therapy"
Lukas Janker: "Eicosanoids as underestimated molecular players relevant for tumor biology and mechanisms of metastasis"
30.09.-3.10.2018 17th Annual World Congress of the Human Proteome Organization HUPO 2018, Orlando, USA
Christopher Gerner: “May mitochondrial dysfunction predispose for cancer?”
29.08.2018 APMRS 2018 - Austrian Proteomics and Metabolomics Research Symposium, Vienna
Astrid Slany: “In-depth proteome profiling of primary human myeloma cells: new insights into hypoxia driven metabolic, anti-apoptotic and immune evasion strategies”
02.07.2018 Agenda Q_Magine & NanoSpin Meeting; Guest Lecture at the Quantum Optics, Quantum Nanophysics & Quantum Information Group of the Faculty of Physics, University of Vienna
Astrid Slany: "Application of mass spectrometry-based proteomics in bioanalysis"
04.-05.05.2018 ASAC–JunganalytikerInnenforum 2018, University of Vienna
Lukas Janker: “Curcumin exerts its antitumor effects in a context dependent fashion”
Benjamin Neuditschko: “Response Profiling of the anti‐cancer drug arsenic trioxide”
Julia Brunmair: “Evaluation of individual metabolic parameters by the analysis of finger sweat samples using liquid chromatography‐mass spectrometry”
19.-20.04.2018 Second International Meeting on Anakoinosis
Christopher Gerner “Integrative Metabolomics with Impact on Survival in Serous Ovarian Cancer”
Lukas Janker “Curcumin exerts its antitumor effects in a context dependent fashion”
Besnik Muqaku “Reprogramming of organ functions via systemic calcium mobilization”
Laura Niederstätter “Immune cells strategies for coping with metabolic stress as cancer model”
21.03.2018 Gesellschaft der Ärzte in Wien
Christopher Gerner “Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia”
>> LINK
20.02.2018 29th MassSpec Forum Vienna
Dominique Kreutz “Curcumin exerts its antitumor effects in a context dependent fashion”
>> LINK
16.03.2018 Invited Guest Lecture at the Medical University of Vienna - Special Research Program SFB-54: "InThro" Cellular Mediators Linking Inflammation and Thrombosis
Dominique Kreutz “Investigation of drug effects by in-depth label-free proteome profiling”
>> LINK
2017
05.10.2017 WBF Expertenforum, Bundesministerium für Verkehr, Innovation und Technologie (BMVIT)
Christopher Gerner “Stellungnahme zum Fachbereich Funk/zelluläre Effekte”
05.10.2017 Inselspital Bern
Christopher Gerner “Novel insights into cancer-associated pathomechanisms by the combined analysis of proteins, metabolites and lipids”
06. – 08.09.2017 - APRS- Austrian Proteomics and Metabolomics Research Symposium – Graz, Austria
Rupert L. Mayer “Aging-related proteome alterations in B cells may predispose for chronic lymphocytic leukemia”
Besnik Muqaku “Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma”
13.–17.08.2017 Metallomics 2017, Vienna, Austria
Christopher Gerner “On the molecular mechanism of action of organometallic anticancer drugs”
03.-06.04.2017 ANAKON 2017, Tübingen, Germany
Christopher Gerner “Combinatory shotgun proteomics and shotgun eicosadomics study of platelets activated by calcium mobilization”
10.-12.04.2017 6th European Lipidomic Meeting ELM 2017, Toulouse, France
Christopher Gerner “The amazing functional plasticity of platelets investigated by combining proteomics with lipidomics”
Laura Niederstaetter “Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation”
12.-14.01.2017 ÖGDV 2017 Science Days, Fuschl am See, Austria
Christopher Gerner “Combined proteomics and lipidomics supports the investigation and discovery of novel pathomechanisms”
2016
13.-15.11.2016 2nd Lipidomics Forum, ISAS, Dortmund, Germany
Christopher Gerner “Dexamethasone fails to inhibit the secretion of several inflammatory chemokines and counteracts the formation of both pro- and anti-inflammatory eicosanoids in human fibroblasts”
14.-15.11.2016 Global Engage’s Mass Spectrometry & Proteomics Congress, London, UK
Christopher Gerner “From novel disease mechanisms to predictive biomarkers: combining proteomics and lipidomics for the investigation of metastatic melanoma”
04.-05.11.2016 25. Jahrestagung der Austrian Breast & Colorectal Cancer Study Group, Saalfelden, Austria
Christopher Gerner “Comprehension of cancer disease mechanisms by the combination of proteomics, lipidomics and metabolomics”
14.10.2016 Department of Analytical Chemistry – RCPTM, Palacky University, Olomouc, Czech Republic, seminar lecture invited by Prof. Karel Lemr
Christopher Gerner “Relating eicosanoid formation with cytokine secretion offers new insight into the regulation of inflammatory processes”
12.-15.09.2016 The 3rd Annual European Congress of The Association for Mass Spectrometry: Applications to the Clinical Lab MSACL 2016 EU, Salzburg, Austria
Christopher Gerner “Metabolomics of Fingersweat: Individual Assessment of Metabolic Parameters based on Fingerprint Analyses”
22.--25.06.2016 X Annual Congress of the European Proteomics Association, Istanbul, Turkey
Besnik Muqaku, Martin Eisinger, Samuel Meier, Astrid Slany, Albrecht Reichle, Christopher Gerner: “Systemic rather than tumor specific energy expenditure processes are responsible for human melanoma-associated cachexia”
09.-11.06.2016 13th Pneumology Update 2016, 13th PneumoUpdate, Igls, Austria, plenary lecture
Christopher Gerner “Metabolomics und Lipidomics beim NSCLC”
10.05.2016 Experimentalvortrag im Zuge der Ausstellung “Die Schönheit der Elemente” im Österreichischen Gesellschafts- und Wirtschaftsmuseum
Christopher Gerner, Peter Unfried “Was ist das? – Alte und neue Methoden der Analytik”
08.-10.05.2016 Time and Light: Novel Concepts and Models in Sensory and Chronobiology, Vienna, Austria
Samuel M. Meier, Clemens Langbauer, Florian Raible, Christopher Gerner “Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry”
31.03./01.04.2016 acib Workshop on Analytical Chemistry 2016, Vienna, invited by Assoc. Prof. Stephan Hann
Astrid Slany, Andrea Bileck, Dominique Kreutz, Rupert L. Mayer, Besnik Muqaku, Christopher Gerner “Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling”
07./08.03.2016 1st International Meeting on Reprogramming Cancer Cells via Anakoinosis as a Novel Anticancer Approach: Facts, Expectations and Open Questions, Rome, Italy
Christopher Gerner “Tumor-stroma interactions investigated by proteomics and metabolomics”
23./24.02.2016 27th MassSpec Forum Vienna 2016, Vienna
Ammar Tahir: “Implementation of an orbitrap based eicosanoids analysis platform for the identification of cell type specific inflammation signature”
Astrid Slany, Andrea Bileck, Dominique Kreutz, Rupert L. Mayer, Besnik Muqaku, Christopher Gerner: “Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling”
Besnik Muqaku, Martin Eisinger, Samuel Meier, Astrid Slany, Albrecht Reichle, Christopher Gerner: “Systemic rather than tumor specific energy expenditure processes are responsible for human melanoma-associated cachexia”
09./10.02.2016 33. Forum Analytik, Vienna
Denise Wolrab, Peter Frühauf, Christopher Gerner: “Die Trennnung von polaren Analyten mittels SFC – Evaluierung von stationären Phasen, Modifier und Additiven”
Christopher Gerner, Besnik Muqaku, Andrea Bileck: “Modulation von Entzündungsprozessen durch Kaffeekonsum: Erfassung individualisierter Zytokin- und Eicosanoid-Signaturen mittels gezielter massenspektrometrischer Analysen”
2015
20.11.2015 Montanuniversität Leoben, Department of General, Analytical and Physical Chemistry, Leoben, Austria, seminar lecture invited by Prof. Wolfhard Wegscheider
Christopher Gerner: “Can we improve the accuracy of measurements of small molecules in biological samples using multi-omics approaches?”
17.11.2015 Gesellschaft der Ärzte in Wien – State of the Art: Proteomics und ihre Bedeutung für die Klinik, Wien, eingeladen von der Gesellschaft der Ärzte in Wien
Astrid Slany: “New insights into tumor biology and drug effects in multiple myeloma obtained by proteome profiling”
Rupert Mayer: “Ultra-Deep mass spectrometry-based proteomics enables new insights into chronic lymphocytic leukemia”
26./27.10.2015 1st International Course Workshop “Biomolecular Recognition and Mass Spectrometry” BRMS-1 2015, Rüsselsheim, Germany
Christopher Gerner: “Assessment of the efficiency of antibody-based protein depletion for serum proteome profiling for the investigation of cancer-associated cachexia”
30.9.2015 University Hospital Regensburg, Regensburg, Germany, seminar lecture invited by Prof. Albrecht Reichle
Christopher Gerner: “Proteome analyses of serum of patients with metastatic melanoma”
21.-24.9.2015 16th Austrian Chemistry Days, Joint Meeting of the Italian & Austrian Chemical Societies, Innsbruck, Austria
Dominique Kreutz, Andrea Bileck, Samuel M. Meier, Bernhard Keppler, Christopher Gerner: “Investigation of novel metal-based anticancer drug candidates’ mechanisms of action by in-depth proteome profiling”
26.-28.8.2015 13th Austrian Proteomic Research Symposium and Late Summer Meeting 2015, APRS2015, Klosterneuburg, Austria
Dominique Kreutz, Andrea Bileck, Astrid Slany, Walter Jäger, Christopher Gerner: “Proteome profiling for evaluation of drug effects – a pilot study using a resveratrol derivative”
20./22.7.2015 British Society for Proteome Research 2015 Meeting, United Kingdom, Reading 2015
Christopher Gerner, Andrea Bileck, Dominique Kreutz, Besnik Muqaku, Rupert Mayer, Astrid Slany: “Proteome signatures of inflammatory primary human mesenchymal cells”
Andrea Bileck, Astrid Slany, Dominique Kreutz, Christopher Gerner: “Evaluation of signalling pathways in primary human peripheral blood mononuclear cells by in-depth proteome profiling”
12./13.6.2015 11th ASAC JunganalytikerInnenforum, Innsbruck 2015
Andrea Bileck, Dominique Kreutz, Astrid Slany, Christopher Gerner: “Comprehensive LC-MS/MS analyses enables assessment of signalling pathways in human blood cells”
Dominique Kreutz, Andrea Bileck, Walter Jäger, Christopher Gerner: “Assessment of drug induced proteome alterations exemplified on four breast cancer cell lines treated with the resveratrol derivative 3,3’,4,4’,5,5’-hexahydroxystilbene”
Rupert Mayer, Samuel Meier, Clemens Langbauer, Christopher Gerner: “Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry”
17./18.04.2015 23. Jahrestagung der Biomedizinischen AnalytikerInnen, Graz
Andrea Bileck: “Proteom-Analysen zeigen unerwartete Effekte von Dexamethason in primären humanen mononukleären Zellen des peripheren Blutes”
17./18.02.2015 26th Mass Spectrometric Discussion-Meeting MassSpec-Forum-Vienna 2015, Vienna
Ammar Tahir, Astrid Slany, Christopher Gerner: “Development of an automated search engine for the LC/MS profiling of eicosanoids”
15.1.2015 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger
Astrid Slany: “Proteomics in cancer research”
2014
20.11.2014 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger
Samuel Meier: “Mass spectrometry based assays in preclinical metallodrug research”
23./24.09.2014 12th Austrian Proteomic Research Symposium APRS 2014, Salzburg
Besnik Muqaku, Andrea Bileck, Dominique Kreutz, Rupert Mayer, Astrid Slany, Christopher Gerner: "MRM-based quantitative secretome analysis of inflammatory activated primary human cells"
Andrea Bileck, Astrid Slany, Michael Groessl, Dominique Kreutz, Kerstin Gloessmann, Georg Pfeiler and Christopher Gerner: "Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblast"
Christopher Gerner, Tamara Weiss, Andrea Bileck, Astrid Slany, Dominique Kreutz, Sabine Taschner-Mandl, Ingeborg M. Ambros, and Peter F. Ambros: "Schwannomics: Profiling Schwann cells as potential prototype for tumor-inhibiting stromal cell"
17.09.2014 30th International Symposium on Chromatography ISC 2014, Salzburg
Christopher Gerner, Besnik Muqaku, Andrea Bileck, Ammar Tahir, Dominique Kreutz, Rupert Mayer, Astrid Slany: "Cell type-specific secretome profiles obtained from inflammatory stimulated primary human cells can be used for drug evaluation"
05.09.2014 The 1st Annual MSACL EU Conference MSACL 2014 EU, Salzburg
Christopher Gerner, Besnik Muqaku, Andrea Bileck, Dominique Kreutz, Rupert Mayer, Astrid Slany: "Inflammatory cytokine and chemokine profiles of primary human cells determined with Chip-HPLC – triple quadrupole mass spectrometry"
02.07.2014 Central and Eastern European Proteomics Conference (CEEPC)
Astrid Slany: “Comparative proteome profiling and targeted proteomics-based drug evaluation”
29.04.2014 1st Vienna Metabolism Club
Gunda Köllensperger, Christopher Gerner: “The Mass Spectrometry Center: A Multi-Purpose Service Center, Integrating Proteomics and Metabolomics for Biomedical Research”
02.04.2014 St. Anna Kinderkrebsforschung, Wien
Seminarvortrag eingeladen von Prof. Dr. Peter Ambros
Tamara Weiss, Christopher Gerner: „Schwann cells: shedding new light on old players in tumor biology”
19.02.2014 MassSpec-Forum Vienna 2014
Astrid Slany, Samuel Meier, Christopher Gerner: „HRMS and MRM based quantitative secretome analysis – a key for assessing cell functions and drug effects”
05.02.2014, Regensburg, Deutschland
Klinikum der Universität Regensburg Seminarvortrag eingeladen von Prof. Dr. Albrecht Reichle
Christopher Gerner: „Evaluation of tumor-suppressive and tumor-promoting stroma cell activities by proteome profiling focussing on secretome analyses“